Human Genome Epidemiology Literature Finder
|
Records 1 - 11 (of 11 Records) |
| Query Trace: Disease and APOBEC3B[original query] |
|---|
| Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population. Journal of viral hepatitis 2013 Oct 20 (10): 678-86. Ezzikouri S, Kitab B, Rebbani K, Marchio A, Wain-Hobson S, Dejean A, Vartanian J-P, Pineau P, Benjelloun |
| Increased expression of intrinsic antiviral genes in HLA-B*57-positive individuals. Journal of leukocyte biology 2013 Nov 94 (5): 1051-9. Raposo Rui André Saraiva, Abdel-Mohsen Mohamed, Holditch Sara J, Kuebler Peter J, Cheng Rex G, Eriksson Emily M, Liao Wilson, Pillai Satish K, Nixon Douglas |
| APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry. Carcinogenesis 2013 Oct 34 (10): 2240-3. Xuan Dennis, Li Guoliang, Cai Qiuyin, Deming-Halverson Sandra, Shrubsole Martha J, Shu Xiao-Ou, Kelley Mark C, Zheng Wei, Long Jiro |
| Lack of association between intact/deletion polymorphisms of the APOBEC3B gene and HIV-1 risk. PloS one 2014 9 (3): e92861. Imahashi Mayumi, Izumi Taisuke, Watanabe Dai, Imamura Junji, Matsuoka Kazuhiro, Ode Hirotaka, Masaoka Takashi, Sato Kei, Kaneko Noriyo, Ichikawa Seiichi, Koyanagi Yoshio, Takaori-Kondo Akifumi, Utsumi Makoto, Yokomaku Yoshiyuki, Shirasaka Takuma, Sugiura Wataru, Iwatani Yasumasa, Naoe Tomo |
| The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer. PloS one 2016 11 (8): e0161731. Liu Jingjing, Sieuwerts Anieta M, Look Maxime P, van der Vlugt-Daane Michelle, Meijer-van Gelder Marion E, Foekens John A, Hollestelle Antoinette, Martens John W |
| APOBEC3B deletion impacts on susceptibility to acquire HIV-1 and its advancement among individuals in western India. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2016 Aug . Singh HariOm, Marathe Shruti D, Nain Sumitra, Nema Vijay, Ghate Manisha V, Gangakhedkar Raman |
| Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population. BMC cancer 2016 16 (1): 165. Marouf Chaymaa, Göhler Stella, Filho Miguel Inacio Da Silva, Hajji Omar, Hemminki Kari, Nadifi Sellama, Försti As |
| Assessment of an APOBEC3B truncating mutation, c.783delG, in patients with breast cancer. Breast cancer research and treatment 2017 Jan . Radmanesh Hoda, Spethmann Tessa, Enßen Julia, Schürmann Peter, Bhuju Sabin, Geffers Robert, Antonenkova Natalia, Khusnutdinova Elza, Sadr-Nabavi Ariane, Shandiz Fatemeh Homaei, Park-Simon Tjoung-Won, Hillemanns Peter, Christiansen Hans, Bogdanova Natalia, Dörk Thi |
| Identifying germline APOBEC3B deletion and immune phenotype in Korean patients with operable breast cancer. Breast cancer research and treatment 2020 7 183 (3): 697-704. Kim Se Hyun, Ahn Soomin, Suh Koung Jin, Kim Yu Jung, Park So Yeon, Kang Eunyoung, Kim Eun-Kyu, Kim In Ah, Chae Sumin, Choi Murim, Kim Jee Hy |
| Prognostic Value of HPV E6 and APOBEC3B in Upper Urinary Tract Urothelial Carcinoma. Disease markers 2022 7 2022 2147494. He Le, Yang Bo, Jian Dan, Luo Hao, Wang Dong, Dai N |
| APOBEC3F expression in triple-negative breast cancer is associated with tumor microenvironment infiltration and activation of cancer immunity and improved survival. American journal of cancer research 2022 3 12 (2): 744-762. Wu Rongrong, Oshi Masanori, Asaoka Mariko, Huyser Michelle R, Tokumaru Yoshihisa, Yamada Akimitsu, Yan Li, Endo Itaru, Ishikawa Takashi, Takabe Kazua |
- Page last reviewed:Feb 1, 2024
- Content source: